Related references
Note: Only part of the references are listed.In Vitro Activity of Pyronaridine against Multidrug-Resistant Plasmodium falciparum and Plasmodium vivax
R. N. Price et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial
Antoinette K. Tshefu et al.
LANCET (2010)
Artemisinin combination therapy for vivax malaria
Nicholas M. Douglas et al.
LANCET INFECTIOUS DISEASES (2010)
Evaluation of chloroquine therapy for vivax and falciparum malaria in southern Sumatra, western Indonesia
Inge Sutanto et al.
MALARIA JOURNAL (2010)
The International Limits and Population at Risk of Plasmodium vivax Transmission in 2009
Carlos A. Guerra et al.
PLOS NEGLECTED TROPICAL DISEASES (2010)
Low efficacy of chloroquine: Time to switchover to artemisinin-based combination therapy for falciparum malaria in India
N. Valecha et al.
ACTA TROPICA (2009)
Case Report: Histopathology of Fatal Respiratory Distress Caused by Plasmodium vivax Malaria
Neena Valecha et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2009)
Plasmodium vivax malaria in children: uncommon manifestations
A. Parakh et al.
ANNALS OF TROPICAL PAEDIATRICS (2009)
Vivax Malaria: A Major Cause of Morbidity in Early Infancy
Jeanne R. Poespoprodjo et al.
CLINICAL INFECTIOUS DISEASES (2009)
Resistance to Therapies for Infection by Plasmodium vivax
J. Kevin Baird
CLINICAL MICROBIOLOGY REVIEWS (2009)
Drug Resistance and in Vitro Susceptibility of Plasmodium falciparum in Thailand during 1988-2003
Nantana Suwandittakul et al.
KOREAN JOURNAL OF PARASITOLOGY (2009)
Plasmodium vivax Malaria: Status in the Republic of Korea Following Reemergence
Jae-Won Park et al.
KOREAN JOURNAL OF PARASITOLOGY (2009)
Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite
Ivo Mueller et al.
LANCET INFECTIOUS DISEASES (2009)
High sensitivity detection of Plasmodium species reveals positive correlations between infections of different species, shifts in age distribution and reduced local variation in Papua New Guinea
Ivo Mueller et al.
MALARIA JOURNAL (2009)
Geographic patterns of Plasmodium falciparum drug resistance distinguished by differential responses to amodiaquine and chloroquine
Juliana Martha Sa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Determinants of in vitro drug susceptibility testing of Plasmodium vivax
B. Russell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Fixed-dose pyronaridine-artesunate combination for treatment of uncomplicated falciparum malaria in pediatric patients in Gabon
Michael Ramharter et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: A prospective study in Papua, Indonesia
Emiliana Tjitra et al.
PLOS MEDICINE (2008)
Susceptibility to chloroquine, mefloquine and artemisinin of Plasmodium vivax in northwestern Thailand
Birgit Woitsch et al.
WIENER KLINISCHE WOCHENSCHRIFT (2007)
Therapeutic efficacy of chloroquine in Plasmodium vivax from areas with different epidemiological patterns in India and their Pvdhfr gene mutation pattern
Neena Valecha et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2006)
Mapping the global extent of malaria in 2005
Carlos A. Guerra et al.
TRENDS IN PARASITOLOGY (2006)
Artemisinin or chloroquine for blood stage Plasmodium vivax malaria in Vietnam
GT Phan et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2002)
Therapeutic responses to different antimalarial drugs in vivax malaria
S Pukrittayakamee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Share Paper
